{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:16:02Z","timestamp":1792844162525,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Teijin Pharma Limited"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s13300-023-01421-5","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T09:03:25Z","timestamp":1684314205000},"page":"1175-1192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Multimorbidity, Polypharmacy, Severe Hypoglycemia, and Glycemic Control in Patients Using Glucose-Lowering Drugs for Type\u00a02 Diabetes: A Retrospective Cohort Study Using Health Insurance Claims in Japan"],"prefix":"10.1007","volume":"14","clinical-trial-number":[{"clinical-trial-number":"umin000046736","registry":"10.18810\/umin-japan"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-1273","authenticated-orcid":false,"given":"Ruriko","family":"Koto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"1421_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37\u201343.","journal-title":"Lancet"},{"key":"1421_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102149","volume":"9","author":"C Violan","year":"2014","unstructured":"Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS ONE. 2014;9: e102149.","journal-title":"PLoS ONE"},{"key":"1421_CR3","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/s41598-018-21917-6","volume":"8","author":"T Aoki","year":"2018","unstructured":"Aoki T, Yamamoto Y, Ikenoue T, Onishi Y, Fukuhara S. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population. Sci Rep. 2018;8:3806.","journal-title":"Sci Rep"},{"key":"1421_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209585","volume":"13","author":"JI Chiang","year":"2018","unstructured":"Chiang JI, Jani BD, Mair FS, et al. Associations between multimorbidity, all-cause mortality and glycaemia in people with type\u00a02 diabetes: a systematic review. PLoS ONE. 2018;13: e0209585.","journal-title":"PLoS ONE"},{"key":"1421_CR5","unstructured":"International Diabetes Federation IDF Diabetes Atlas, 9th ed. Brussels, Belgium. 2019. https:\/\/www.diabetesatlas.org. Accessed 16 Aug 2022."},{"issue":"Suppl 1","key":"1421_CR6","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.2337\/dc22-S013","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 13. Older adults: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S195\u2013207.","journal-title":"Diabetes Care"},{"key":"1421_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/ijerph15020310","volume":"15","author":"V P\u00e9rez-Jover","year":"2018","unstructured":"P\u00e9rez-Jover V, Mira JJ, Carratala-Munuera C, et al. Inappropriate use of medication by elderly, polymedicated, or multipathological patients with chronic diseases. Int J Environ Res Public Health. 2018;15:310.","journal-title":"Int J Environ Res Public Health"},{"key":"1421_CR8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/ggi.12890","volume":"16","author":"T Kojima","year":"2016","unstructured":"Kojima T, Mizukami K, Tomita N, et al. Screening tool for older persons\u2019 appropriate prescriptions for Japanese: report of the Japan Geriatrics Society Working Group on \u201cGuidelines for medical treatment and its safety in the elderly.\u201d Geriatr Gerontol Int. 2016;16:983\u20131001.","journal-title":"Geriatr Gerontol Int"},{"key":"1421_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11606-009-1179-2","volume":"25","author":"ES Huang","year":"2010","unstructured":"Huang ES, Karter AJ, Danielson KK, Warton EM, Ahmed AT. The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study. J Gen Intern Med. 2010;25:141\u20136.","journal-title":"J Gen Intern Med"},{"key":"1421_CR10","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","volume":"363","author":"S Zoungas","year":"2010","unstructured":"Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363:1410\u20138.","journal-title":"N Engl J Med"},{"key":"1421_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b4909","volume":"340","author":"DE Bonds","year":"2010","unstructured":"Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type\u00a02 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340: b4909.","journal-title":"BMJ"},{"key":"1421_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.4158\/EP12382.OR","volume":"19","author":"RG McCoy","year":"2013","unstructured":"McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Self-report of hypoglycemia and health-related quality of life in patients with type 1 and type\u00a02 diabetes. Endocr Pract. 2013;19:792\u20139.","journal-title":"Endocr Pract"},{"key":"1421_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.19099","volume":"3","author":"RG McCoy","year":"2020","unstructured":"McCoy RG, Lipska KJ, Van Houten HK, Shah ND. Association of cumulative multimorbidity, glycemic control, and medication use with hypoglycemia-related emergency department visits and hospitalizations among adults with diabetes. JAMA Netw Open. 2020;3:e1919099.","journal-title":"JAMA Netw Open"},{"key":"1421_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11892-018-1018-0","volume":"18","author":"R Silbert","year":"2018","unstructured":"Silbert R, Salcido-Montenegro A, Rodriguez-Gutierrez R, Katabi A, McCoy RG. Hypoglycemia among patients with type\u00a02 diabetes: epidemiology, risk factors, and prevention strategies. Curr Diab Rep. 2018;18:53.","journal-title":"Curr Diab Rep"},{"issue":"61","key":"1421_CR15","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","volume":"2018","author":"MJ Davies","year":"2018","unstructured":"Davies MJ, D\u2019Alessio DA, Fradkin J, et al. Management of hyperglycaemia in type\u00a02 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018;2018(61):2461\u201398.","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"1421_CR16","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.2337\/dc22-S006","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 6. Glycemic targets: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S83-96.","journal-title":"Diabetes Care"},{"key":"1421_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13340-020-00439-5","volume":"11","author":"E Araki","year":"2020","unstructured":"Araki E, Goto A, Kondo T, et al. Japanese clinical practice guideline for diabetes 2019. Diabetol Int. 2020;11:165\u2013223.","journal-title":"Diabetol Int"},{"key":"1421_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jamainternmed.2013.12963","volume":"174","author":"CL Tseng","year":"2014","unstructured":"Tseng CL, Soroka O, Maney M, Aron DC, Pogach LM. Assessing potential glycemic overtreatment in persons at hypoglycemic risk. JAMA Intern Med. 2014;174:259\u201368.","journal-title":"JAMA Intern Med"},{"key":"1421_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamainternmed.2014.7345","volume":"175","author":"KJ Lipska","year":"2015","unstructured":"Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015;175:356\u201362.","journal-title":"JAMA Intern Med"},{"key":"1421_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2337\/dc16-0985","volume":"40","author":"KJ Lipska","year":"2017","unstructured":"Lipska KJ, Yao X, Herrin J, et al. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006\u20132013. Diabetes Care. 2017;40:468\u201375.","journal-title":"Diabetes Care"},{"key":"1421_CR21","doi-asserted-by":"publisher","first-page":"E142","DOI":"10.5888\/pcd15.180255","volume":"15","author":"E Styles","year":"2018","unstructured":"Styles E, Kidney RSM, Carlin C, Peterson K. Diabetes treatment, control, and hospitalization among adults aged 18 to 44 in Minnesota, 2013\u20132015. Prev Chronic Dis. 2018;15:E142.","journal-title":"Prev Chronic Dis"},{"key":"1421_CR22","first-page":"190","volume":"5","author":"A Okada","year":"2022","unstructured":"Okada A, Yasunaga H. Prevalence of noncommunicable diseases in Japan using a newly developed administrative claims database covering young, middle-aged, and elderly people. JMA J. 2022;5:190\u20138.","journal-title":"JMA J"},{"key":"1421_CR23","unstructured":"Ministry of Health, Labour and Welfare. An outline of the Japanese medical system. https:\/\/www.mhlw.go.jp\/english\/policy\/health-medical\/health-insurance\/index.html. Accessed 2 Apr 2021."},{"key":"1421_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-001007","volume":"8","author":"RG McCoy","year":"2020","unstructured":"McCoy RG, Lipska KJ, Van Houten HK, Shah ND. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes. BMJ Open Diabetes Res Care. 2020;8: e001007.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1421_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.7326\/M17-1362","volume":"167","author":"PR Conlin","year":"2017","unstructured":"Conlin PR, Colburn J, Aron D, Pries RM, Tschanz MP, Pogach L. Synopsis of the 2017 U.S. Department of Veterans Affairs\/U.S. Department of Defense clinical practice guideline: management of type\u00a02 diabetes mellitus. Ann Intern Med. 2017;167:655\u201363.","journal-title":"Ann Intern Med"},{"key":"1421_CR26","unstructured":"The Management of Type\u00a02 Diabetes Mellitus in Primary Care Work Group. VA\/DoD clinical practice guideline for the management of type\u00a02 diabetes mellitus in primary care 2017. https:\/\/www.healthquality.va.gov\/guidelines\/CD\/diabetes\/VADoDDMCPGFinal508.pdf. Accessed 16 Aug 2022."},{"key":"1421_CR27","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/jgs.12035","volume":"60","author":"MS Kirkman","year":"2012","unstructured":"Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012;60:2342\u201356.","journal-title":"J Am Geriatr Soc"},{"key":"1421_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/jdi.12778","volume":"9","author":"Y Ikeda","year":"2018","unstructured":"Ikeda Y, Kubo T, Oda E, Abe M, Tokita S. Incidence rate and patient characteristics of severe hypoglycemia in treated type\u00a02 diabetes mellitus patients in Japan: retrospective diagnosis procedure combination database analysis. J Diabetes Investig. 2018;9:925\u201336.","journal-title":"J Diabetes Investig"},{"key":"1421_CR29","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S2213-8587(19)30081-6","volume":"7","author":"D Selvarajah","year":"2019","unstructured":"Selvarajah D, Kar D, Khunti K, et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7:938\u201348.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1421_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57:6\u201314.","journal-title":"Br J Clin Pharmacol"},{"key":"1421_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025806","volume":"9","author":"R Nishimura","year":"2019","unstructured":"Nishimura R, Kato H, Kisanuki K, et al. Treatment patterns, persistence and adherence rates in patients with type\u00a02 diabetes mellitus in Japan: a claims-based cohort study. BMJ Open. 2019;9: e025806.","journal-title":"BMJ Open"},{"key":"1421_CR32","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/jdi.13636","volume":"13","author":"R Bouchi","year":"2022","unstructured":"Bouchi R, Sugiyama T, Goto A, et al. Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type\u00a02 diabetes in Japan. J Diabetes Investig. 2022;13:280\u201391.","journal-title":"J Diabetes Investig"},{"issue":"63","key":"1421_CR33","first-page":"221","volume":"2020","author":"JB Buse","year":"2018","unstructured":"Buse JB, Wexler DJ, Tsapas A, et al. 2019 Update to: management of hyperglycaemia in type\u00a02 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2020;63:221\u20138.","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"1421_CR34","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.2337\/dc21-S009","volume":"44","author":"American Diabetes Association Professional Practice Committee","year":"2021","unstructured":"American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S111\u201324.","journal-title":"Diabetes Care"},{"key":"1421_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2020;41:255\u2013323.","journal-title":"Eur Heart J"},{"key":"1421_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001029","volume":"94","author":"A Sako","year":"2015","unstructured":"Sako A, Yasunaga H, Matsui H, et al. Hospitalization for hypoglycemia in Japanese diabetic patients: a retrospective study using a national inpatient database, 2008\u20132012. Medicine (Baltimore). 2015;94: e1029.","journal-title":"Medicine (Baltimore)"},{"key":"1421_CR37","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/dme.13660","volume":"35","author":"N Nanayakkara","year":"2018","unstructured":"Nanayakkara N, Pease AJ, Ranasinha S, et al. Younger people with type\u00a02 diabetes have poorer self-care practices compared with older people: results from the Australian National Diabetes Audit. Diabet Med. 2018;35:1087\u201395.","journal-title":"Diabet Med"},{"key":"1421_CR38","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/jcm8040420","volume":"8","author":"CC Hsiao","year":"2019","unstructured":"Hsiao CC, Tu HT, Lin CH, Chen KH, Yeh YH, See LC. Temporal trends of severe hypoglycemia and subsequent mortality in patients with advanced diabetic kidney diseases transitioning to dialysis. J Clin Med. 2019;8:420.","journal-title":"J Clin Med"},{"key":"1421_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2021.108946","volume":"178","author":"SE Lee","year":"2021","unstructured":"Lee SE, Kim KA, Son KJ, et al. Trends and risk factors in severe hypoglycemia among individuals with type\u00a02 diabetes in Korea. Diabetes Res Clin Pract. 2021;178:1\u20137.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1421_CR40","first-page":"1","volume":"7","author":"S Al\u00e3o","year":"2021","unstructured":"Al\u00e3o S, Concei\u00e7\u00e3o J, Dores J, et al. Hypoglycemic episodes in hospitalized people with diabetes in Portugal: the HIPOS-WARD study. Clin Diabetes Endocrinol. 2021;7:1\u201312.","journal-title":"Clin Diabetes Endocrinol"},{"issue":"5","key":"1421_CR41","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s13300-020-00779-0","volume":"11","author":"A Sonmez","year":"2020","unstructured":"Sonmez A, Tasci I, Demirci I, et al. A cross-sectional study of overtreatment and deintensification of antidiabetic and antihypertensive medications in diabetes mellitus: the TEMD Overtreatment Study. Diabetes Ther. 2020;11:1045\u201359.","journal-title":"Diabetes Ther"},{"key":"1421_CR42","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2666-7568(20)30014-3","volume":"1","author":"P Hanlon","year":"2020","unstructured":"Hanlon P, Faur\u00e9 I, Corcoran N, et al. Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis. Lancet Healthy Longev. 2020;1:e106\u201316.","journal-title":"Lancet Healthy Longev"},{"key":"1421_CR43","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/bcp.13590","volume":"84","author":"M Guti\u00e9rrez-Valencia","year":"2018","unstructured":"Guti\u00e9rrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero \u00c1, Inzitari M, Martinez-Velilla N. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84:1432\u201344.","journal-title":"Br J Clin Pharmacol"},{"key":"1421_CR44","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.2337\/dc20-2664","volume":"44","author":"TN Nguyen","year":"2021","unstructured":"Nguyen TN, Harris K, Woodward M, et al. The Impact of frailty on the effectiveness and safety of intensive glucose control and blood pressure-lowering therapy for people with type\u00a02 diabetes: results from the ADVANCE trial. Diabetes Care. 2021;44:1622\u20139.","journal-title":"Diabetes Care"},{"key":"1421_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/gerona\/glq208","volume":"66","author":"C Diederichs","year":"2011","unstructured":"Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases\u2014a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci. 2011;66:301\u201311.","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-023-01421-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-023-01421-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-023-01421-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T16:41:45Z","timestamp":1685983305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-023-01421-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1421"],"URL":"https:\/\/doi.org\/10.1007\/s13300-023-01421-5","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}